Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capeci...

por Pivot, Xavier, Im, Seock Ah, Guo, Matthew, Marmé, Frederik
Publicado 2018

Reimagining Undergraduate Medical Education in a Post-COVID-19 Landscape

por Guo, Matthew Z., Allen, Jawara, Sakumoto, Matthew, Pahwa, Amit, Santhosh, Lekshmi
Publicado 2022

Prolonged duration of response in lenvatinib responders with thyroid cancer

por Gianoukakis, Andrew G, Dutcus, Corina E, Batty, Nicolas, Guo, Matthew, Baig, Mahadi
Publicado 2018

Indirect treatment comparisons including network meta-analysis: Lenvatinib plus everolimus for the second-line treatment of advanced/metastatic renal cell carcinoma

por Tremblay, Gabriel, McElroy, Heather J., Westley, Tracy, Meier, Genevieve, Misurski, Derek, Guo, Matthew
Publicado 2019

Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion Diagnostics

por Guo, Matthew Z, Marrone, Kristen A, Spira, Alexander, Waterhouse, David M, Scott, Susan C
Publicado 2021

Two Cases of Subsequent Hepatocellular Carcinoma in Immune Checkpoint Inhibitor–Responsive NSCLC: A Case Report

por Cheunkarndee, Tia, Guo, Matthew Z., Birkness-Gartman, Jacqueline E., Oshima, Kiyoko, Lin, Cheng Ting, Marrone, Kristen A.
Publicado 2022

Benchmark dose analyses of multiple genetic toxicity endpoints permit robust, cross-tissue comparisons of MutaMouse responses to orally delivered benzo[a]pyrene

por Long, Alexandra S., Wills, John W., Krolak, Dorothy, Guo, Matthew, Dertinger, Stephen D., Arlt, Volker M., White, Paul A.
Publicado 2017

Targeting Cancer Stem Cells with Differentiation Agents as an Alternative to Genotoxic Chemotherapy for the Treatment of Malignant Testicular Germ Cell Tumors

por Loehr, Amanda R., Pierpont, Timothy M., Gelsleichter, Eric, Galang, Anabella Maria D., Fernandez, Irma R., Moore, Elizabeth S., Guo, Matthew Z., Miller, Andrew D., Weiss, Robert S.
Publicado 2021

A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine

por Twelves, Chris, Anthoney, Alan, Savulsky, Claudio I., Guo, Matthew, Reyderman, Larisa, Cresti, Nicola, Semiglazov, Vladimir, Timcheva, Constanta, Zubairi, Ishtiaq, Morrison, Rosemary, Plummer, Ruth, Evans, T. R. Jeffry
Publicado 2019

Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes

por Pasca, Sergiu, Guo, Matthew Z., Wang, Shiyu, Stokvis, Kristin, Shedeck, Audra, Pallavajjala, Aparna, Shams, Cynthia, Pallavajjala, Roshni, DeZern, Amy E., Varadhan, Ravi, Gocke, Christopher D., Jones, Richard J., Gondek, Lukasz P.
Publicado 2023

Racial and Ethnic Disparities in Outcomes Among Newborns with Congenital Diaphragmatic Hernia

por Sferra, Shelby R., Salvi, Pooja S., Penikis, Annalise B., Weller, Jennine H., Canner, Joseph K., Guo, Matthew, Engwall-Gill, Abigail J., Rhee, Daniel S., Collaco, Joseph M., Keiser, Amaris M., Solomon, Daniel G., Kunisaki, Shaun M.
Publicado 2023

Multiple 9-1-1 complexes promote homolog synapsis, DSB repair, and ATR signaling during mammalian meiosis

por Pereira, Catalina, Arroyo-Martinez, Gerardo A, Guo, Matthew Z, Downey, Michael S, Kelly, Emma R, Grive, Kathryn J, Mahadevaiah, Shantha K, Sims, Jennie R, Faca, Vitor M, Tsai, Charlton, Schiltz, Carl J, Wit, Niek, Jacobs, Heinz, Clark, Nathan L, Freire, Raimundo, Turner, James, Lyndaker, Amy M, Brieno-Enriquez, Miguel A, Cohen, Paula E, Smolka, Marcus B, Weiss, Robert S
Publicado 2022

Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)

por Berry, Sneha, Giraldo, Nicolas, Nguyen, Peter, Green, Benjamin, Xu, Haiying, Ogurtsova, Aleksandra, Soni, Abha, Succaria, Farah, Wang, Daphne, Roberts, Charles, Stein, Julie, Engle, Elizabeth, Pardoll, Drew, Anders, Robert, Cottrell, Tricia, Taube, Janis M., Tran, Ben, Voskoboynik, Mark, Kuo, James, Bang, Yung-Lue, Chung, Hyun-Cheo, Ahn, Myung-Ju, Kim, Sang-We, Perera, Ayesh, Freeman, Daniel, Achour, Ikbel, Faggioni, Raffaella, Xiao, Feng, Ferte, Charles, Lemech, Charlotte, Meric-Bernstam, Funda, Werner, Theresa, Hodi, Stephen, Messersmith, Wells, Lewis, Nancy, Talluto, Craig, Dostalek, Mirek, Tao, Aiyang, McWhirter, Sarah, Trujillo, Damian, Luke, Jason, Xu, Chunxiao, BoMarelli, Qi, Jin, Qin, Guozhong, Yu, Huakui, Jenkins, Molly, Lo, Kin-Ming, Halle, Joern-Peter, Lan, Yan, Taylor, Matthew, Vogelzang, Nicholas, Cohn, Allen, Stepan, Daniel, Shumaker, Robert, Dutcus, Corina, Guo, Matthew, Schmidt, Emmett, Rasco, Drew, Brose, Marcia, Vogelzang, Nicholas, Di Simone, Christopher, Jain, Sharad, Richards, Donald, Encarnacion, Carlos, Rasco, Drew, Shumaker, Robert, Dutcus, Corina, Stepan, Daniel, Guo, Matthew, Schmidt, Emmett, Taylor, Matthew, Vogelzang, Nicholas, Encarnacion, Carlos, Cohn, Allen, Di Simone, Christopher, Rasco, Drew, Richards, Donald, Taylor, Matthew, Dutcus, Corina, Stepan, Daniel, Shumaker, Robert, Guo, Matthew, Schmidt, Emmett, Mier, James, An, Jeongshin, Yang, Yeun-yeoul, Lee, Won-Hee, Yang, Jinho, Kim, Jong-kyu, Kim, Hyun Goo, Paek, Se Hyun, Lee, Jun Woo, Woo, Joohyun, Kim, Jong Bin, Kwon, Hyungju, Lim, Woosung, Paik, Nam Sun, Kim, Yoon-Keun, Moon, Byung-In, Janku, Filip, Tan, David, Martin-Liberal, Juan, Takahashi, Shunji, Geva, Ravit, Gucalp, Ayca, Chen, Xueying, Subramanian, Kulandayan, Mataraza, Jennifer, Wheler, Jennifer, Bedard, Philippe
Publicado 2019